The US government plans to discontinue the Johnson & Johnson vaccine amid concerns about blood clots in vaccinated people, the NYT was quoted as saying by Business Insider.
Six women who have been vaccinated with the Johnson & Johnson vaccine have developed blood clots, writes NYT, which notes, however, that this is a rare side effect.
Last week, the European Medicines Agency announced that it had begun examining reports of bleeding in people receiving the Johnson & Johnson vaccine, along with cases of the AstraZeneca vaccine.
Four serious cases of low blood platelet clots, including one fatal, have been reported after immunization with the vaccine produced by Janssen, the European subsidiary of the US pharmaceutical company Johnson & Johnson.
Previously, the FDA had established that no link had been established between clots and Johnson & Johnson vaccination.
– .
